ClinConnect ClinConnect Logo
Search / Trial NCT02411682

Breakfast on Postprandial Hyperglycemia

Launched by HOSPITAL DE CLINICAS CARACAS · Apr 7, 2015

Trial Information

Current as of August 26, 2025

Unknown status

Keywords

ClinConnect Summary

In type 2 diabetic individuals the omission of breakfast is associated with significant increase in HbA1C and all-day postprandial hyperglycemia even without overeating in the evening. In contrast, high-energy breakfast and low-energy dinner result in a significant reduction of all-day postprandial glycaemia Similarly, 3 months of high-energy breakfast led to a 5% reduction in HbA1C levels in type 2 diabetes participants Despite the growing evidence showing the beneficial effects of breakfast consumption on overall postprandial hyperglycemia and HbA1C levels, very little is known regarding ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • BMI: 26-34 kg/m2.
  • HbA1c \> 7 %
  • T2D since \< 10 yrs,
  • . Only non treated or treated with oral antidiabetic drugs
  • Those treated with insulin or GLP-1 analogs will be excluded.
  • Exclusion Criteria:
  • Type 1 diabetes
  • Serum creatinine level \> 1.5 mg/dl
  • Pulmonary disease, psychiatric, immunological, neoplastic diseases or severe diabetic complications,such as cardiovascular disease, cerebrovascular disease, proliferative diabetic retinopathy, gastroparesis or anemia (Hg \> 10g/dL) or underwent bariatric surgery.
  • Abnormal liver function tests
  • Participating in dietary program or using of weight-loss medications
  • History (within one year) of illicit drug abuse or alcoholism.
  • Use of psychotropic or anoretic medication during the month immediately prior to study onset

About Hospital De Clinicas Caracas

Hospital de Clínicas Caracas is a leading healthcare institution in Venezuela, renowned for its commitment to providing high-quality medical care and advancing clinical research. As a prominent sponsor of clinical trials, the hospital fosters innovative research initiatives aimed at enhancing patient outcomes and contributing to the global medical community. With a multidisciplinary team of experienced healthcare professionals and researchers, Hospital de Clínicas Caracas emphasizes ethical standards, patient safety, and scientific rigor in its clinical investigations, making it a pivotal player in the field of medical research in the region.

Locations

Patients applied

0 patients applied

Trial Officials

Daniela Jakubowicz, MD

Principal Investigator

Hospital de Clinicas Caracas

Daniela Jakubowicz, MD

Principal Investigator

E. Wolfson Medical Center. Israel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials